BDTX
Price
$2.23
Change
-$0.16 (-6.69%)
Updated
Feb 5, 02:27 PM (EDT)
Capitalization
136.17M
41 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.54
Change
-$0.20 (-5.35%)
Updated
Feb 5, 04:06 PM (EDT)
Capitalization
208.22M
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs VYGR

Header iconBDTX vs VYGR Comparison
Open Charts BDTX vs VYGRBanner chart's image
Black Diamond Therapeutics
Price$2.23
Change-$0.16 (-6.69%)
Volume$100
Capitalization136.17M
Voyager Therapeutics
Price$3.54
Change-$0.20 (-5.35%)
Volume$7.25K
Capitalization208.22M
BDTX vs VYGR Comparison Chart in %
BDTX
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDTX vs. VYGR commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a StrongBuy and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (BDTX: $2.39 vs. VYGR: $3.74)
Brand notoriety: BDTX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 105% vs. VYGR: 173%
Market capitalization -- BDTX: $136.17M vs. VYGR: $208.22M
BDTX [@Biotechnology] is valued at $136.17M. VYGR’s [@Biotechnology] market capitalization is $208.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDTX and VYGR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • BDTX’s TA Score: 4 bullish, 3 bearish.
  • VYGR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BDTX is a better buy in the short-term than VYGR.

Price Growth

BDTX (@Biotechnology) experienced а -7.00% price change this week, while VYGR (@Biotechnology) price change was -5.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

BDTX is expected to report earnings on Mar 18, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($208M) has a higher market cap than BDTX($136M). BDTX has higher P/E ratio than VYGR: BDTX (6.46) vs VYGR (6.00). BDTX YTD gains are higher at: -1.646 vs. VYGR (-4.835). BDTX has higher annual earnings (EBITDA): 12.2M vs. VYGR (-136.19M). BDTX has more cash in the bank: 136M vs. VYGR (45.1M). BDTX has less debt than VYGR: BDTX (19.7M) vs VYGR (38.4M). BDTX has higher revenues than VYGR: BDTX (70M) vs VYGR (31.3M).
BDTXVYGRBDTX / VYGR
Capitalization136M208M65%
EBITDA12.2M-136.19M-9%
Gain YTD-1.646-4.83534%
P/E Ratio6.466.00108%
Revenue70M31.3M224%
Total Cash136M45.1M302%
Total Debt19.7M38.4M51%
FUNDAMENTALS RATINGS
BDTX vs VYGR: Fundamental Ratings
BDTX
VYGR
OUTLOOK RATING
1..100
656
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4697
PRICE GROWTH RATING
1..100
6261
P/E GROWTH RATING
1..100
9910
SEASONALITY SCORE
1..100
8565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (47) in the Biotechnology industry is in the same range as BDTX (48) in the null industry. This means that VYGR’s stock grew similarly to BDTX’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BDTX (100) in the null industry. This means that VYGR’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's SMR Rating (46) in the null industry is somewhat better than the same rating for VYGR (97) in the Biotechnology industry. This means that BDTX’s stock grew somewhat faster than VYGR’s over the last 12 months.

VYGR's Price Growth Rating (61) in the Biotechnology industry is in the same range as BDTX (62) in the null industry. This means that VYGR’s stock grew similarly to BDTX’s over the last 12 months.

VYGR's P/E Growth Rating (10) in the Biotechnology industry is significantly better than the same rating for BDTX (99) in the null industry. This means that VYGR’s stock grew significantly faster than BDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDTXVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGGY6.42N/A
N/A
Alliance Global Group, Inc.
ELEZF35.45N/A
N/A
Endesa S.A.
ERVFF0.03N/A
N/A
Boron One Holdings Inc.
PCCWY7.63N/A
N/A
PCCW Limited
IRCDF1.37N/A
N/A
Intercede Group PLC

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been closely correlated with ARCT. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BDTX jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-5.16%
ARCT - BDTX
66%
Closely correlated
+0.14%
BCAB - BDTX
64%
Loosely correlated
+11.06%
VTGN - BDTX
63%
Loosely correlated
-3.20%
CRBU - BDTX
62%
Loosely correlated
+3.85%
MREO - BDTX
61%
Loosely correlated
-2.73%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-4.35%
RGNX - VYGR
55%
Loosely correlated
-1.01%
XNCR - VYGR
53%
Loosely correlated
-3.84%
CRSP - VYGR
52%
Loosely correlated
-3.52%
BDTX - VYGR
51%
Loosely correlated
-5.16%
OCUL - VYGR
50%
Loosely correlated
+0.47%
More